US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jun 11, 2020 (6 years ago)

Irinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Defective Container: Customer complaints received of a crimp defect while removing the flip-cap during use.

What was recalled

Irinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Shiffgraben 23, 38690 Golsar, Germany Distributed by: West-Word Pharmaceutical Corp. Eatontown, NJ 07724 USA, NDC 0143-9701-01

Recalling firm
Hikma Pharmaceuticals USA Inc.
NDC code
0143-9701-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1308-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Irinotecan recalls

See all